Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update

Glioblastoma is the most common malignant primary brain tumor in adults. The prognosis is extremely poor even with standard treatment of maximal safe resection, radiotherapy, and chemotherapy. Recurrence is inevitable within months, and treatment options are very limited. Chimeric antigen receptor T...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsajjan, Roa, Mason, Warren P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529026/
https://www.ncbi.nlm.nih.gov/pubmed/37754534
http://dx.doi.org/10.3390/curroncol30090619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529026/
https://www.ncbi.nlm.nih.gov/pubmed/37754534
http://dx.doi.org/10.3390/curroncol30090619

Ejemplares similares